J Korean Acad Child Adolesc Psychiatry.
2012 Sep;23(3):103-108.
Change of Quality of Life in Children with ADHD after 12 Weeks OROS-Methylphenidate Treatment
- Affiliations
-
- 1Department of Psychiatry, Seoul National University Hospital, Seoul, Korea. kbn1@snu.ac.kr
- 2Department of Psychiatry, Seoul National University Bundang Hospital, Seongnam, Korea.
- 3Department of Psychiatry, Pusan National University Hospital, Busan, Korea.
- 4Department of Psychiatry, Chungbuk National University Hospital, Cheongju, Korea.
- 5Department of Psychiatry, Ajou University Hospital, Suwon, Korea.
- 6Department of Psychiatry, Kyungpook National University Hospital, Daegu, Korea.
- 7Department of Psychiatry, Chung-Ang University Hospital, Seoul, Korea.
Abstract
OBJECTIVES
The aim of this study is to investigate the effectiveness of treatment with osmotic-release oral system methylphenidate (OROS-MPH) on quality of life (QOL) in children with attention-deficit hyperactivity disorder (ADHD). Another aim is to assess the relationship between change in QOL and other factors including children's symptoms and academic performance or parents' depression and parenting stress.
METHODS
A total of 111 medication-naive children with ADHD in a multicenter, open-label, 12-week trial of OROS-MPH completed an evaluation using diverse rating scales at two time points; at baseline and after 12 weeks of treatment. Scales for investigation of children included the Parent Report Form-Children's Health and Illness Profile-Children's Edition (PRF-CHIP-CE) on QOL, the ADHD Rating Scale-IV on symptoms, and the Academic Performance Rating Scale (APRS). The Beck Depression Inventory and Parenting Stress Index were used for assessment of their parents.
RESULTS
Total scores for mean PRF-CHIP-CE increased from 207.9+/-26.7 at baseline to 226.3+/-25.9 after 12 weeks of treatment (p<.001). The change of APRS showed the strongest correlation with the increment of PRF-CHIP-CE scores (Pearson coefficient= 0.561, p<.001), even after controlling for other factors (partial correlation coefficient=0.420, p<.001).
CONCLUSION
Treatment with MPH-OROS results in improvement of QOL in children with ADHD in Korea. The advance in academic performance plays a key role in this change of QOL.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Efficacy of OROS Methylphenidate for the Treatment of ADHD
- A Brief Replication Study Comparing Stimulants and Non-Stimulants for Attention-Deficit/Hyperactivity Disorder Treatment with a Focus on the Compliance, Efficacy, and Satisfaction
- OROS Methylphenidate Treatment of Secondary Adult ADHD after Traumatic Brain Injury
- Effect of Methylphenidate on Sleep Parameters in Children with ADHD
- Titrating Optimal Dose of Osmotic-Controlled Release Oral Delivery (OROS)-Methylphenidate and Its Efficacy and Safety in Korean Children with ADHD: A Multisite Open Labeled Study
